Breaking News
October 20, 2018 - Case Comprehensive Cancer Center wins NIH grant to study health disparities
October 20, 2018 - Newly discovered compound shows potential for treating Parkinson’s disease
October 20, 2018 - High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients
October 20, 2018 - Immunotherapy medicine found to be effective in treating uveitis
October 20, 2018 - The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
October 20, 2018 - Female internists consistently earn less than men
October 20, 2018 - Stanford team looks at dangers of teens’ vaping habits
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Dysfunction of single gene leads to miscarriages
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
October 19, 2018 - Speech Pathology Australia raises awareness about Developmental Language Disorder
October 19, 2018 - Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers
October 19, 2018 - Survey finds high prevalence of HTLV-1 infection among teens and adults in Gabon
October 19, 2018 - Bliss funds research to find whether parental touch can help alleviate pain in premature infants
October 19, 2018 - Human neurons employ highly compartmentalized signaling, study shows
October 19, 2018 - Ultromics expands multiple clinical trials for coronary heart disease to the U.S.
October 19, 2018 - $11 million NIH grant for Clemson University helps launch new center for musculoskeletal research
October 19, 2018 - A new approach identified to control Zika virus, dengue fever
October 19, 2018 - Head Blows Without Concussion May Not Damage Brain, Study Claims
October 19, 2018 - US opioid use not declined, despite focus on abuse and awareness of risk
October 19, 2018 - Next-generation RNA sequencing technology sheds new light on human mitochondrial diseases
October 19, 2018 - UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery
October 19, 2018 - The immune system also plays a key role in day-to-day function of healthy organs
October 19, 2018 - New tool may reveal how the brain structure impacts brain activity, human behavior
October 19, 2018 - Trump Administration announces ‘Winning on Reducing Food Waste’ initiative
October 19, 2018 - For-profit nursing home residents more likely to experience health issues caused by substandard care
October 19, 2018 - Incidence of stroke has risen steadily among marijuana users, show studies
October 19, 2018 - Conceptual framework proposed to examine role of exercise in multiple sclerosis
October 19, 2018 - Near infrared spectroscopy technique for accurate evaluation of chondral injuries
October 19, 2018 - Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
October 19, 2018 - Shorter physician encounters associated with antibiotic prescribing
October 19, 2018 - In the Spotlight: Enjoying research and exploring opportunities
October 19, 2018 - Physical activity lowers cardiovascular mortality risk in frail older adults
October 19, 2018 - New imaging tool helps visualize how sound-induced vibrations travel through the ear
October 19, 2018 - Key insights into the application, production of bioactive materials
October 19, 2018 - New urea sorbent could speed up the development of wearable artificial kidney
October 19, 2018 - Intensive care patients’ muscles less able to use fats for energy
October 19, 2018 - FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain

The Current issue of “The view from here” is concerned with Models

image_pdfDownload PDFimage_print

The excitement of the Football World Cup is now over and we are well into the holiday season. This might be the silly season for the newspaper industry, but we get no such break in the white heat of Drug Discovery as covered by Drug Discovery Today. This month’s offering covers a very diverse field – that of models. We are all familiar with the use of models in our industry, but as with many concepts everybody’s concept differs. That is reflected in our offering this month and I hope you agree that we cover a wide range of “models” ranging from development using modern gene editing tools, to cutting edge in vitro models and animal models that have all shown themselves to be essential in advancing drug development.


The first article in this month’s offering is entitled: “Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery”, by Gulzar Ahmad and Mansoor Amiji of The Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston,  USA. In this article, the authors provide insights into how the incredibly powerful editing tool, CRISPR/Cas9, can be used to create in vitro and in vivo models for the drug discovery industry capable of enhancing speed and capacity. The impact of the use of this technique has the real potential of accelerating the identification and validation of high value targets, essential for the move into precision medicine in the future.


The second article in the series moves away from the molecular biological arena, to the cell biology world. In particular it highlights a field that is becoming ever more influential, especially in (but not exclusive to) the field of oncology. It is by Miryam Mebarki, Annelise Bennaceur and Laurence Bonhomme-Faivre of the APHP-Hopital Paul Brousse Université, Paris, France and is entitled: “Human cell derived organoids as a new ex vivo model for drug assays in oncology”. It is not many years since the mainstay of screening for compounds for oncology were 2D culture models. I don’t have the space (or time) in this newsletter editorial to debate the pros and cons of 2D versus 3D drug screens, but it is fair to say that in general the more physiologically-relevant the culture system the more likely the hits from it will be relevant to the treatment of the disease in in vivo models. Some of the most exciting developments in compound screening in the past few years has been the practical development of what is essentially an ex vivo model system consisting of a 3D culture of stem cells to produce “organoids” – structures that are effectively phenotypic, replicates of the intended target organ. The article describes the development of the technique, in particular its applications in oncology and indicates the scope and limitations of the approach in preclinical studies.


Last, but by no means least, we feature the article by Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang and Keld Fosgerau of Gubra Aps, Denmark  entitled: “Mouse models of nonalcoholic steatohepatitis in preclinical drug development” In contrast with the other two articles, this one covers a field that is very familiar to everyone within the pharmaceutical industry, which is the in vivo animal model. Although for ethical and economic reasons, there has been pressure to reduce animal usage and to reduce our reliance on animal models, they have endured as the best extrapolation from in vitro to human disease. Whether this will change in the future remains the subject of much debate, it is unlikely that animal models will disappear from the drug discovery project map in the near future, if ever. This particular article deals with mouse models of a disease that is becoming more and more prominent in the Western world, such that it is now the major cause of chronic liver disease. The authors discuss the possible causes and pathogenesis of the disease and those strategies that have been adopted to find agents that may interfere with the process. They go on to describe in some detail the models that have been used to investigate drugs that may prove effective and the current status of trials of compounds intended to treat this disease.



Steve Carney was born in Liverpool, England and studied Biochemistry at Liverpool University, obtaining a BSc.(Hons) and then read for a PhD on the Biochemistry and Pathology of Connective Tissue Diseases in Manchester University, in the Departments of Medical Biochemistry and Histopathology. On completion of his PhD he moved to the Kennedy Institute of Rheumatology, London, where he worked with Professor Helen Muir FRS and Professor Tim Hardingham, on the biochemistry of experimental Osteoarthritis. He joined Eli Lilly and Co. and held a number of positions in Biology R&D, initially in the Connective Tissue Department, but latterly in the Neuroscience Department. He left Lilly to take up his present position as Managing Editor, Drug Discovery Today, at Elsevier. Currently, he also holds an honorary lectureship in Drug Discovery at the University of Surrey, UK. He has authored over 50 articles in peer-reviewed journals, written several book chapters and has held a number of patents. In the last month, Dr. Carney has extended his television and film portfolio by appearing in the Disney film “Christopher Robin”, a natural progression of his in-demand tenor horn skills that have in the past been seen on national TV in the UK (BBC, ITV, channel 4) and France (France 2) and in TV movies such as Harry Price: Ghost Hunter. Other major developments are in the pipeline, so please watch here for developments.


Tagged with:

About author

Related Articles